Cargando…

Type 2 Immunity and Its Impact on COVID-19 Infection in the Airways

Type 2 immune responses are characterized by elevated type 2 cytokines and blood eosinophilia. Emerging evidence suggests that people with chronic type 2 inflammatory lung diseases are not particularly susceptible to SARS-CoV-2 infection. Intriguingly, recent in vitro, ex vivo research demonstrates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pathinayake, Prabuddha S., Awatade, Nikhil T., Wark, Peter A. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967553/ https://www.ncbi.nlm.nih.gov/pubmed/36851616 http://dx.doi.org/10.3390/v15020402

Ejemplares similares

Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights
por: Wark, Peter A.B., et al.
Publicado: (2021)

Innate Immunity and Immune Evasion by Enterovirus 71
por: Pathinayake, Prabuddha S., et al.
Publicado: (2015)

Comparison of commercially available differentiation media on cell morphology, function, and anti-viral responses in conditionally reprogrammed human bronchial epithelial cells
por: Awatade, Nikhil T., et al.
Publicado: (2023)

Understanding the Unfolded Protein Response in the Pathogenesis of Asthma
por: Pathinayake, Prabuddha S., et al.
Publicado: (2018)

Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study
por: Dey, Surajit, et al.
Publicado: (2023)

Differential airway remodeling changes were observed in patients with asthma COPD overlap compared to patients with asthma and COPD alone
por: Dey, Surajit, et al.
Publicado: (2022)

The Complex Association between COPD and COVID-19
por: Awatade, Nikhil T., et al.
Publicado: (2023)

Antiviral immunity is impaired in COPD patients with frequent exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2019)

Hypersegmented airway neutrophils and its association with reduced lung function in adults with obstructive airway disease: an exploratory study
por: Lokwani, Ravi, et al.
Publicado: (2019)

Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing
por: Johansen, Matt D., et al.
Publicado: (2022)

Airway Epithelial Cell Immunity Is Delayed During Rhinovirus Infection in Asthma and COPD
por: Veerati, Punnam Chander, et al.
Publicado: (2020)

Airway Mycosis and the Regulation of Type 2 Immunity
por: Knight, John Morgan, et al.
Publicado: (2020)

Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway via degradation of RIG-I and MDA5
por: Weerawardhana, Asela, et al.
Publicado: (2022)

Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection
por: Veerati, Punnam Chander, et al.
Publicado: (2023)

The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders
por: Chong, Wai Chin, et al.
Publicado: (2021)

Innate immune response to viral infection of the lungs
por: See, Hayley, et al.
Publicado: (2008)

Airway Epithelial-Derived Immune Mediators in COVID-19
por: Guo, Tony J. F., et al.
Publicado: (2023)

Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation
por: Lv, Jiajia, et al.
Publicado: (2018)

Type 2 Diabetes and its Impact on the Immune System
por: Berbudi, Afiat, et al.
Publicado: (2020)

Impact of pregnancy on airway complications after intubation for COVID-19 infection: A case series()()
por: Vasudevan, Ananya, et al.
Publicado: (2022)

Airway in the Airway
por: Sharma, Ankur, et al.
Publicado: (2021)

A systematic review of the direct and indirect COVID-19’s impact on food security and its dimensions: pre-and post-comparative analysis
por: Gebeyehu, Daniel Teshome, et al.
Publicado: (2023)

Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19
por: Taboe, Hemaho B., et al.
Publicado: (2023)

Viral Infection and Airway Epithelial Immunity in Asthma
por: Kim, So Ri
Publicado: (2022)

Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect
por: Wong, Sharon L., et al.
Publicado: (2022)

Asthma and the Dysregulated Immune Response to Rhinovirus
por: Wark, Peter A. B.
Publicado: (2020)

Livin promotes Th2-type immune response in airway allergic diseases
por: Wang, Yue, et al.
Publicado: (2022)

Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab
por: Cook, Alistair, et al.
Publicado: (2021)

Novel Antioxidant Therapy with the Immediate Precursor to Glutathione, γ-Glutamylcysteine (GGC), Ameliorates LPS-Induced Cellular Stress in In Vitro 3D-Differentiated Airway Model from Primary Cystic Fibrosis Human Bronchial Cells
por: Hewson, Chris K., et al.
Publicado: (2020)

Airway immune responses to COVID-19 vaccination in COPD patients and healthy subjects
por: Southworth, Thomas, et al.
Publicado: (2022)

Covid-19 and its impact on immunization programs: reflections from Brazil
por: Matos, Camila Carvalho de Souza Amorim, et al.
Publicado: (2020)

Dysregulation of the Immune Environment in the Airways During HIV Infection
por: Bunjun, Rubina, et al.
Publicado: (2021)

Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine
por: Awatade, Nikhil T., et al.
Publicado: (2018)

Insulin sensitivity index (ISI(0, 120)) potentially linked to carbon isotopes of breath CO(2) for pre-diabetes and type 2 diabetes
por: Ghosh, Chiranjit, et al.
Publicado: (2015)

Recommendations for Prehospital Airway Management in Patients with Suspected COVID-19 Infection
por: Hart, James, et al.
Publicado: (2020)

A Protection Tent for Airway Management in Patients With COVID-19 Infection
por: Fang, Pin-Hui, et al.
Publicado: (2020)

Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response
por: Cunha, Lucas Leite, et al.
Publicado: (2020)

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2018)

Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications
por: Nagata, Naoyoshi, et al.
Publicado: (2023)

The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi
por: Chan, Louisa L. Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_76um9rtqp15uppofsdf28ujhkv